Last reviewed · How we verify
Lidocaine 2% with 1:100 000 epinephrine — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Lidocaine 2% with 1:100 000 epinephrine (Lidocaine 2% with 1:100 000 epinephrine) — St. Joseph's Healthcare Hamilton.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lidocaine 2% with 1:100 000 epinephrine TARGET | Lidocaine 2% with 1:100 000 epinephrine | St. Joseph's Healthcare Hamilton | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lidocaine 2% with 1:100 000 epinephrine CI watch — RSS
- Lidocaine 2% with 1:100 000 epinephrine CI watch — Atom
- Lidocaine 2% with 1:100 000 epinephrine CI watch — JSON
- Lidocaine 2% with 1:100 000 epinephrine alone — RSS
Cite this brief
Drug Landscape (2026). Lidocaine 2% with 1:100 000 epinephrine — Competitive Intelligence Brief. https://druglandscape.com/ci/lidocaine-2-with-1-100-000-epinephrine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab